Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway.

Wang, Ping; Cui, Jiayue; Wen, Jihong; Guo, Yunhui; Zhang, Liangzi; Chen, Xia

Wang, Ping; Cui, Jiayue; Wen, Jihong; Guo, Yunhui; Zhang, Liangzi; Chen, Xia.

Afiliación

Wang P; Department of Otolaryngology-Head and Neck Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Cui J; Department of Histology and Embryology, College of Basic Medical Sciences Jilin University, Changchun, Jilin 130021, P.R. China.
Wen J; Department of Gynaecology and Obstetrics, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Guo Y; Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.
Zhang L; Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.
Chen X; Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.

Oncol Lett ; 12(6): 4605-4612, 2016 Dec.

Article en En | MEDLINE | ID: mdl-28105167

Palabras clave

cisplatin; drug targets; hepatocellular carcinoma; long noncoding RNA; p53 signaling pathway

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2016 Tipo del documento: Article